The letter points out that copay increases place financial burdens on TRICARE beneficiaries and restrict patient access. In addition, restricting patient access could adversely impact medication compliance and actually increase health costs.
So far in 2016, there have been multiple Part D plans and PBMs that have been utilizing MAC drug pricing values that are "far below what would be considered to be reasonably approaching market prices for drugs," the letter noted.
Global Citizen is reporting that GlaxoSmithKline will be granting licenses to generics manufacturers in lower middle-income countries in a move aimed at increasing access to medicine in low-income countries. The company announced the changes at the end of March, noting that rather than attempting to enforce its patents, it would move to a licensing model, charging a small fee to generics manufacturers. (Global Citizen)
The study found that Walgreens pharmacy patients who used a multi-faceted medication adherence program had a 3% higher medication adherence rate and lower healthcare costs than those who use other pharmacies.
The report attributes the growth to a concurrent increase in chronic pain in the United States, stemming from an aging population and more incidences of such chronic diseases as diabetes, obesity, cancer, arthritis and cardiovascular disease.
Deloitte’s new whitepaper, “Retail health & wellness: Innovation, convergence and healthier consumers” offers background and insights into how and why retailers are making the large shift toward more robust health and wellness offerings.
The complaint alleges that Endo paid Impax Laboratories and Watson Laboratories, which were the first companies to file for FDA approval for generics of Endo’s Opana ER and Lidoderm, to delay their generic product launches.
Russia Beyond the Headlines is reporting that in Russia, following the news in early March that tennis star Maria Sharapova tested positive for meldonium, sales of the drug — which costs about $4 to $5 (300 rubles) and which many pharmacies sell without a prescription — have risen dramatically. According to the report, many of those buying the drug are amateur athletes. (RBTH)
The fifth edition of this special Rx-Impact report — inserted in headquarter copies of this issue of DSN and delivered to all current members of the U.S. House of Representatives and Senate — is meant to help educate lawmakers on the important role community pharmacy plays as the face of health care in neighborhoods all across America, helping to lower the cost of health care, improving patient access, advancing the quality of care and ultimately delivering better outcomes.